Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles

Coronavirus disease 2019 (COVID-19) has caused a global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral infection is reliant upon the binding between angiotensin-converting enzyme 2 receptor (ACE2) and spike protein (S). Therefore, ACE2 is a key receptor for SARS-...

Full description

Bibliographic Details
Main Authors: Soha Y. Alkhaldi, Ian Peng, Ching-An Peng
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Bioengineering
Subjects:
Online Access:https://www.mdpi.com/2306-5354/10/6/652
_version_ 1797596054639607808
author Soha Y. Alkhaldi
Ian Peng
Ching-An Peng
author_facet Soha Y. Alkhaldi
Ian Peng
Ching-An Peng
author_sort Soha Y. Alkhaldi
collection DOAJ
description Coronavirus disease 2019 (COVID-19) has caused a global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral infection is reliant upon the binding between angiotensin-converting enzyme 2 receptor (ACE2) and spike protein (S). Therefore, ACE2 is a key receptor for SARS-CoV-2 to infect the host. Nonetheless, as SARS-CoV-2 is constantly mutating into new variants that cause high infection rates, the development of prophylactic and therapeutic approaches remains a necessity to continue fighting mutated SARS-CoV-2 variants. In this study, ACE2-streptavidin fusion proteins expressed by recombinant DNA technology were anchored on biotinylated fluorescent polystyrene particles of various sizes ranging from 0.15 to 5 µm. The ACE2-tethered micro/nanoparticles were shown to prevent spike protein pseudotyped lentivirus entry into ACE2-expressing HEK293T cells. Compared to ACE2 in soluble form, micro-sized particles (2 and 5 µm) immobilized with ACE2 interfered more efficiently with viral attachment, entry, and the ensuing infection. Our results showed that particles functionalized with ACE2 could be used as efficient decoys to block the infection of SARS-CoV-2 strains.
first_indexed 2024-03-11T02:46:06Z
format Article
id doaj.art-ce845b7fc9584674a323aef76659143c
institution Directory Open Access Journal
issn 2306-5354
language English
last_indexed 2024-03-11T02:46:06Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Bioengineering
spelling doaj.art-ce845b7fc9584674a323aef76659143c2023-11-18T09:20:53ZengMDPI AGBioengineering2306-53542023-05-0110665210.3390/bioengineering10060652Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/NanoparticlesSoha Y. Alkhaldi0Ian Peng1Ching-An Peng2Department of Chemical and Biological Engineering, University of Idaho, Moscow, ID 83844, USADepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID 83844, USADepartment of Chemical and Biological Engineering, University of Idaho, Moscow, ID 83844, USACoronavirus disease 2019 (COVID-19) has caused a global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral infection is reliant upon the binding between angiotensin-converting enzyme 2 receptor (ACE2) and spike protein (S). Therefore, ACE2 is a key receptor for SARS-CoV-2 to infect the host. Nonetheless, as SARS-CoV-2 is constantly mutating into new variants that cause high infection rates, the development of prophylactic and therapeutic approaches remains a necessity to continue fighting mutated SARS-CoV-2 variants. In this study, ACE2-streptavidin fusion proteins expressed by recombinant DNA technology were anchored on biotinylated fluorescent polystyrene particles of various sizes ranging from 0.15 to 5 µm. The ACE2-tethered micro/nanoparticles were shown to prevent spike protein pseudotyped lentivirus entry into ACE2-expressing HEK293T cells. Compared to ACE2 in soluble form, micro-sized particles (2 and 5 µm) immobilized with ACE2 interfered more efficiently with viral attachment, entry, and the ensuing infection. Our results showed that particles functionalized with ACE2 could be used as efficient decoys to block the infection of SARS-CoV-2 strains.https://www.mdpi.com/2306-5354/10/6/652SARS-CoV-2ACE2spike proteinpseudotyped lentivirusfunctionalized particlescore streptavidin
spellingShingle Soha Y. Alkhaldi
Ian Peng
Ching-An Peng
Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
Bioengineering
SARS-CoV-2
ACE2
spike protein
pseudotyped lentivirus
functionalized particles
core streptavidin
title Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
title_full Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
title_fullStr Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
title_full_unstemmed Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
title_short Inhibition of SARS-CoV-2 Spike Protein Pseudotyped Virus Infection Using ACE2-Tethered Micro/Nanoparticles
title_sort inhibition of sars cov 2 spike protein pseudotyped virus infection using ace2 tethered micro nanoparticles
topic SARS-CoV-2
ACE2
spike protein
pseudotyped lentivirus
functionalized particles
core streptavidin
url https://www.mdpi.com/2306-5354/10/6/652
work_keys_str_mv AT sohayalkhaldi inhibitionofsarscov2spikeproteinpseudotypedvirusinfectionusingace2tetheredmicronanoparticles
AT ianpeng inhibitionofsarscov2spikeproteinpseudotypedvirusinfectionusingace2tetheredmicronanoparticles
AT chinganpeng inhibitionofsarscov2spikeproteinpseudotypedvirusinfectionusingace2tetheredmicronanoparticles